These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8687435)

  • 21. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
    Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
    Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutational analysis of the transforming growth factor beta receptor type II gene in human ovarian carcinoma.
    Lynch MA; Nakashima R; Song H; DeGroff VL; Wang D; Enomoto T; Weghorst CM
    Cancer Res; 1998 Oct; 58(19):4227-32. PubMed ID: 9766642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter methylation of TGFbeta receptor I and mutation of TGFbeta receptor II are frequent events in MSI sporadic gastric carcinomas.
    Pinto M; Oliveira C; Cirnes L; Carlos Machado J; Ramires M; Nogueira A; Carneiro F; Seruca R
    J Pathol; 2003 May; 200(1):32-8. PubMed ID: 12692838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1.
    Fralix KD; Zhao S; Venkatasubbarao K; Freeman JW
    J Cell Physiol; 2003 Jan; 194(1):88-99. PubMed ID: 12447993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Int7G24A variant of transforming growth factor-beta receptor type I is associated with invasive breast cancer.
    Chen T; Jackson CR; Link A; Markey MP; Colligan BM; Douglass LE; Pemberton JO; Deddens JA; Graff JR; Carter JH
    Clin Cancer Res; 2006 Jan; 12(2):392-7. PubMed ID: 16428477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological significance of altered loci of replication error and microsatellite instability-associated mutations in gastric cancer.
    Wu MS; Lee CW; Shun CT; Wang HP; Lee WJ; Sheu JC; Lin JT
    Cancer Res; 1998 Apr; 58(7):1494-7. PubMed ID: 9537253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mechanism of resistance to growth inhibition by transforming growth factor-beta 1 (TGF-beta 1) in primary lung cancer and new molecular targets in therapy].
    Gemma A; Uematsu K; Hagiwara K; Takenoshita S; Kudoh S
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1253-9. PubMed ID: 10945024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric cancer cell lines: Implication for the loss of TGF-beta type II receptor expression.
    Park SH; Kim YS; Park BK; Hougaard S; Kim SJ
    Oncogene; 2001 Mar; 20(10):1235-45. PubMed ID: 11313868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation.
    Jakowlew SB; Moody TW; Mariano JM
    Anticancer Res; 1997; 17(3C):1849-60. PubMed ID: 9216635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations of E2F-4 trinucleotide repeats in colorectal cancer with microsatellite instability.
    Yoshitaka T; Matsubara N; Ikeda M; Tanino M; Hanafusa H; Tanaka N; Shimizu K
    Biochem Biophys Res Commun; 1996 Oct; 227(2):553-7. PubMed ID: 8878551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A transforming growth factor beta type II receptor gene mutation common in sporadic cecum cancer with microsatellite instability.
    Togo G; Toda N; Kanai F; Kato N; Shiratori Y; Kishi K; Imazeki F; Makuuchi M; Omata M
    Cancer Res; 1996 Dec; 56(24):5620-3. PubMed ID: 8971166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of recombinant human soluble type II transforming growth factor-beta receptor in Pichia pastoris and Escherichia coli: two powerful systems to express a potent inhibitor of transforming growth factor-beta.
    Glansbeek HL; van Beuningen HM; Vitters EL; van der Kraan PM; van den Berg WB
    Protein Expr Purif; 1998 Mar; 12(2):201-7. PubMed ID: 9518461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mutation analysis of transforming growth factor-beta type II receptor gene in human gastric cancer tissues].
    Ke Y; Hagiwara K; Su X
    Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):25-7. PubMed ID: 10743049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivation of the transforming growth factor beta type II receptor in human small cell lung cancer cell lines.
    Hougaard S; Nørgaard P; Abrahamsen N; Moses HL; Spang-Thomsen M; Skovgaard Poulsen H
    Br J Cancer; 1999 Mar; 79(7-8):1005-11. PubMed ID: 10098728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells.
    Miyafuji Y; Zhong X; Uchida I; Koi M; Hemmi H
    J Cell Physiol; 2001 Jun; 187(3):356-64. PubMed ID: 11319759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach, and colorectum.
    Ouyang H; Shiwaku HO; Hagiwara H; Miura K; Abe T; Kato Y; Ohtani H; Shiiba K; Souza RF; Meltzer SJ; Horii A
    Cancer Res; 1997 May; 57(10):1851-4. PubMed ID: 9157973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations of microsatellite instability target genes in sporadic basal cell carcinomas.
    Saetta AA; Stamatelli A; Karlou M; Michalopoulos NV; Patsouris E; Aroni K
    Pathol Res Pract; 2007; 203(12):849-55. PubMed ID: 17950544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations of transforming growth factor-beta 1 receptor type II occur in ulcerative colitis-associated carcinomas, sporadic colorectal neoplasms, and esophageal carcinomas, but not in gastric neoplasms.
    Souza RF; Garrigue-Antar L; Lei J; Yin J; Appel R; Vellucci VF; Zou TT; Zhou X; Wang S; Rhyu MG; Cymes K; Chan O; Park WS; Krasna MJ; Greenwald BD; Cottrell J; Abraham JM; Simms L; Leggett B; Young J; Harpaz N; Reiss M; Meltzer SJ
    Hum Cell; 1996 Sep; 9(3):229-36. PubMed ID: 9183654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Damage to the transforming growth factor TGF-beta type II receptor gene and microsatellite instability in carcinoma cells of the gastrointestinal tract].
    Vostriukhina OA; Nikiforova IF; Shtam TA; Kantorov SL; Kovalev VK; Vasil'ev SV; Pozharisskiī KM; Lantsov VA
    Vopr Onkol; 1998; 44(6):667-71. PubMed ID: 10087960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.